Literature DB >> 19775319

Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels.

A-S Bargnoux1, A-M Dupuy, V Garrigue, I Jaussent, G Gahide, S Badiou, I Szwarc, S Deleuze, H Vernhet, J-P Cristol, G Mourad.   

Abstract

We prospectively assessed the evolution of coronary artery calcification (CAC) and osteoprotegerin (OPG) levels after renal transplantation (RT). Eighty-three recipients were followed-up prospectively during 1 year. Blood was collected before (baseline) and after RT for determination of mineral metabolism parameters including OPG. CAC was measured by multidetector computed tomography at transplantation (baseline) and 1 year later. Progression of CAC was defined as a difference between the follow-up square-root transformed volume (SRV) and the baseline SRV >or= 2.5. By multivariate analysis, baseline OPG level, age and low LDL levels were significantly associated with baseline CAC. RT was accompanied by mineral metabolism improvement with a decrease of OPG from 955 [395-5652] to 527 [217-1818] pg/mL and parathyroid hormone from 94 [1-550] to 62 [16-410] pg/mL. Thirty-one percent of patients did not exhibit CAC at baseline. CAC diminished in 14.5%, stabilized in 59.2% and progressed in 26.3% of patients. Baseline CAC was associated with progression (OR 2.92 [1.02-8.36]). No significant association was found between OPG and CAC progression despite a higher baseline OPG level in progressors (1046 [456-3285]) vs. non-progressors (899 [396-5952] pg/mL). CAC at baseline, but not 1 year after RT, is independently associated with baseline OPG; posttransplant CAC progression is predicted by baseline CAC score.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775319     DOI: 10.1111/j.1600-6143.2009.02814.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  18 in total

Review 1.  Osteoprotegerin and kidney disease.

Authors:  Alejandra Montañez-Barragán; Isaias Gómez-Barrera; Maria D Sanchez-Niño; Alvaro C Ucero; Liliana González-Espinoza; Alberto Ortiz
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.

Authors:  Anne-Sophie Bargnoux; Fernando Vetromile; Nils Kuster; Julie Barberet; Anne-Marie Dupuy; Jean Ribstein; Georges Mourad; Jean-Paul Cristol; Pierre Fesler
Journal:  J Nephrol       Date:  2015-04-29       Impact factor: 3.902

Review 3.  Vascular calcification, bone and mineral metabolism after kidney transplantation.

Authors:  Luis D'Marco; Antonio Bellasi; Sandro Mazzaferro; Paolo Raggi
Journal:  World J Transplant       Date:  2015-12-24

Review 4.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

5.  Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease.

Authors:  Michalis Spartalis; Aikaterini Papagianni
Journal:  World J Nephrol       Date:  2016-01-06

6.  Lowering vascular calcification burden in chronic kidney disease: Is it possible?

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2013-08-06

7.  Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.

Authors:  Abdullah Ozkok; Yasar Caliskan; Tamer Sakaci; Gaye Erten; Gonca Karahan; Alper Ozel; Abdulkadir Unsal; Alaattin Yildiz
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

Review 8.  Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?

Authors:  Thanh-Mai Vo; Sinee Disthabanchong
Journal:  World J Cardiol       Date:  2014-05-26

Review 9.  Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Authors:  Oscar Leonard; Jonas Spaak; David Goldsmith
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

10.  Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.

Authors:  Sibel Gulcicek; Carmine Zoccali; Deniz Çebi Olgun; Giovanni Tripepi; Selma Alagoz; Serkan Feyyaz Yalın; Sinan Trabulus; Mehmet R Altiparmak; Nurhan Seyahi
Journal:  Cardiorenal Med       Date:  2017-07-13       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.